WARNING: CERTAIN ANTIBIOTICS MAY CAUSE PERMANENT NERVE DAMAGE

Similar documents
MEDICATION GUIDE FLOXIN [Flox in] (ofloxacin)

3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose

Update on Fluoroquinolones. Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Moxifloxacin tablets (as moxifloxacin hydrochloride)

OFLOXACIN TABLETS MEDICATION GUIDE

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

FDA-Approved Medication Guide MEDICATION GUIDE Moxifloxacin Hydrochloride Tablets (mox'' i flox' a sin hye'' droe klor' ide) Rx only

Can levaquin treat group b strep

AZITHROMYCIN, DOXYCYCLINE, AND FLUOROQUINOLONES

Cipro and the aorta Fluoroquinolone attack? Bulat A. Ziganshin, MD, PhD and John A. Elefteriades, MD, PhD (hon)

ECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018

IMPORTANT MEDICINE SAFETY INFORMATION

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Antibiotics: Take a Time Out

When the side effects of medications are worse than the ailments they're prescribed for

Author - Dr. Josie Traub-Dargatz

CLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES THE AMINOGLYCOSIDES:

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

WHY IS THIS IMPORTANT?

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

SUMMARY OF PRODUCT CHARACTERISTICS

ANTIMICROBIAL STEWARDSHIP: THE ROLE OF THE CLINICIAN SAM GUREVITZ PHARM D, CGP BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES

Terry Talks Nutrition: Infectious microbes

ANNEX III AMENDMENTS TO THE SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Antibiotic Resistance

Antimicrobial use in poultry: Emerging public health problem

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?

Antibiotic Stewardship in the LTC Setting

IMPORTANT MEDICINE SAFETY INFORMATION

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

These life-saving drugs have been a boon to medical care and benefited hundreds of million patients around the globe.

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Originally posted February 13, Update: March 26, 2018

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Why Don t These Drugs Work Anymore? Biosciences in the 21 st Century Dr. Amber Rice October 28, 2013

moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering

DNA Gyrase Inhibitors, Sulfa drugs and VRE

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

running head: SUPERBUGS Humphreys 1

Dangerous Foods For Cats (Source:

CLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Antibacterial Agents & Conditions. Stijn van der Veen

Warm Up What recommendations do you have for him? Choose a partner and list some suggestions in your lab notebook.

Group b strep and macrodantin

Keeping Antibiotics Working: Nursing Leadership in Action

SUMMARY OF PRODUCT CHARACTERISTICS

Antibiotic stewardship in long term care

Today s Agenda: 9/30/14

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Multi-Drug Resistant Organisms (MDRO)

FDA Announcement. For Immediate Release. Contact. Announcement. February 13, Consumers

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

Cephalosporins, Quinolones and Co-amoxiclav Prescribing Audit

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu

SECTION 3A. Section 3A Criteria for Optional Special Authorization of Select Drug Products

VI.B.2 Elements for a public summary. VI.B.2.1 Overview of disease epidemiology

Simplicef is Used to Treat Animals with Skin Infections

Lyme Disease. Lyme disease is a bacterial infection spread by tick bites from infected blacklegged

Feline Wellness Report

Antimicrobial Stewardship in Ambulatory Care

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

folate-derived cofactors purines pyrimidines Sulfonamides sulfa drugs Trimethoprim infecting bacterium to perform DNA synthesis cotrimoxazole

Archive entry. Content:

SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

ANTIBIOTICS. 21 st century time bomb. By Keith Wassung

The War on Microbes. Chapter Four

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

Routine Drug Use in Livestock and Poultry What Consumers Can Do. Food Safety and Sustainability Center at Consumer Reports

Principles of Antimicrobial Therapy

Antimicrobial Resistance

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Topical Antibiotic Update. Brad Sutton, O.D., F.A.A.O. Indiana University School of Optometry Indianapolis Eye Care Center No financial disclosures

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Copyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at

Fingernails. Smooth (no pits or grooves) Uniform in color Have no spots or discoloration

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

Received: Accepted: Access this article online Website: Quick Response Code:

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

Elements for a Public Summary

Transcription:

WARNING: CERTAIN ANTIBIOTICS MAY CAUSE PERMANENT NERVE DAMAGE By Dr. Michael John Badanek, BS, DC, CNS, CTTP, DACBN, DCBCN, MSGR./CHEV In the past 36 plus years of clinical practice of Integrative/Functional Medicine, I have witnessed a continual spiral of increased neurological conditions from the chronic administration of prescription medications. It will be revealed to the readers of this publication the types of medications along with the secondary consequences with prolonged use of these medications. Please keep in mind that this brief expose is only but a tip of the ice-burg in regard to chronic use of antibiotics with the conditions discussed below. Bear in mind that there are many disease states and chronic debilitating conditions which occur with long term use of any kind of prescription medication so the reader should always beware of any secondary complications when taking any type of medication(s)! Peripheral neuropathy is nerve damage in the arms and/or legs, characterized by pain, burning, tingling, numbness, weakness, or a change in sensation to light touch, pain or temperature, or sense of body position. This is not the first warning FDA has posted about this family of antibacterial drugs. In 2008, they posted a black box warning about severe tendon damage. Now having the additional warning for severe and sometimes permanent nerve damage, there should be NO question in your mind about the danger of these drugs, and I strongly recommend avoiding them if at all possible. Just Say Know (NO)! Fluoroquinolones, a class of synthetic antibacterial drugs are the only types that directly inhibit bacterial DNA synthesis. Several drugs, in this class have been taken off the market due to their deadly adverse effects, but six of them remain FDA-approved for use in the United States: Ciprofloxacin (Cipro) Gemifloxacin (Factive) Norfloxacin (Noroxin) Levofloxacin (Levaquin)

Moxifloxacin (Avelox) Ofloxacin (Floxin) Due to their tremendous health risks, fluoroquinolones should be reserved for treating serious bacterial infections that won t respond to any other treatment when the patient is made fully aware of the potential for serious adverse events. Instead, they re often inappropriately prescribed for mild conditions like sinus, urinary tract and ear infections. In fact, fluoroquinolones are among the most commonly prescribed antibiotics in the United States. I highly recommend you take pause before filling a prescription for these drugs, especially if you have a routine infection that has not been treated by other agents that have a safer side effect profile. You should not expose yourself to this degree of risk unnecessarily! The dangerousness of fluoroquinolones definitely warrants some serious discourse with your health care provider about whether they are really necessary, versus safer treatment options. Fluoroquinolones may be the deadliest antibiotics on the market. Besides nerve damage, they have been associated with damage to other body systems, including your musculoskeletal system, eyes and kidneys. What makes these particular drugs so hazardous? It has to do with the fact that fluoroquinolones are antibiotics whose potency has been kicked up by the addition of a fluoride molecule. Fluoride increases permeability, into hard-to-penetrate tissues, such as your brain. Fluoroquinolones are quinolones with fluoride molecules attached so they penetrate your blood-brain barrier. This ability to penetrate sensitive tissues is what makes fluoride such a potent neurotoxin, able to get into your brain and damage your central nervous system. In terms of peripheral neuropathy, the FDA was not exactly quick to take action. Twelve years ago Dr. Jay Cohen documented the following fluoroquinolonesrelated reactions, and as you can see, nervous system problems topped the list. Yet it took more than a decade-and many destroyed lives-for the FDA to take action.

Nervous system symptoms occurred in 91 percent of patients, taking Fluoroquinolones (pain, tingling and numbness, dizziness, malaise, weakness, headaches, anxiety, panic, loss of memory, psychosis) Musculoskeletal symptoms in 73 percent of patients (tendon ruptures, tendonitis, weakness, joint swelling) Sensory symptoms in 42 percent of patients (tinnitus, altered visual, olfactory, and auditory function) Cardiovascular symptoms in 36 percent of patients (tachycardia, shortness of breath, chest pains, palpitations) Skin reactions in 29 percent of patients (rashes, hair loss, sweating, intolerance to heat or cold) Gastrointestinal symptoms in 18 percent of patients (nausea, vomiting, diarrhea, abdominal pain) Levaquin, the best selling antibiotic in 2010, actually faces thousands of lawsuits per year from people who have been seriously harmed by taking it. The serious reactions reported from Levaquin include: Retinal detachment, which can cause blindness Acute kidney failure Brain Fog Depression Hallucinations Psychotic reactions Painful rashes Phototoxicity Nausea and Diarrhea Healing problems Disruptions to blood sugar metabolism Peripheral neuropathy Fluoroquinolones Destroy Collagen

Animal studies have shown that fluoroquinolones are directly toxic to collagen synthesis and promote collagen degradation. Fluoride disrupts collagen synthesis, which may be part of the reason that fluoridated pharmaceuticals can damage your muscles, tendons, cartilage, ligaments and other structures. The fluoroquinolones seem to have an especially detrimental effect on your musculoskeletal system, presumably related to this adverse effect on collagen, which can lead to tendon damage and actual tendon ruptures. This resulted in the FDA s issuing of a black box warning about tendon damage in 2008. Fluoroquinolones are not the only drugs suped up by the addition of a fluoride molecule. Prozac (fluoxetine), Prevacid, Baycol, and Daimane (flurazepam) are also fluorinated. Are We Heading for Even MORE FDA Warnings? Two other recent studies may foreshadow even more warnings about fluoroquinolones, in terms of liver toxicity and greater risks for people with diabetes. Are we nearing the time when these drugs should be yanked off pharmacy shelves altogether, rather than just receiving more warnings on their labels? Moxifloxacin and levofloxacin were found to increase the risk for acute liver toxicity in people age 66 and up. The findings were published in the Canadian Medical Association Journal in August 2012. The authors recommended FDA consider regulatory warnings acute liver toxicity. Oral fluoroquinolones cause an increased risk of dysglycemia (high blood sugar or low blood sugar reactions) for those with diabetes, according to a study in the August 14, 2013 issue of Clinical Infectious Diseases. Fluoroquinolone Antibiotic Resistance is Much Greater than Predicted Fluoroquinolones contribute to the creation of antibiotic-resistant bacteria to a much greater degree than experts predicted, according to a report in Frontiers of Microbiology.

Since quinolones are synthetic antibiotics, it was predicted that mutations in target genes would be the only mechanisms through which resistance could be acquired, because there will not be quinolone-resistance genes in nature. Contrary to this prediction, a variety of elements ranging from efflux pumps, target-protecting proteins and even quinolone-modifying enzymes have been shown to contribute to quinolone resistance. The finding of some of these elements in plasmids indicates that quinolone resistance can be transferable, Failure to predict the development of quinolone resistance reinforces the need of taking into consideration the wide plasticity of biological systems for future predictions. This plasticity allows pathogens to deal with toxic compounds, including those with a synthetic origin as quinolones. Not only are these antibiotics overused in people, but also in livestock (cows, pigs, chickens, turkeys and in our canine and feline companions. Every year in the US, 29 million pounds of antibiotics more than 70 percent of the total antibiotic production are fed to livestock for nontherapeutic purposes, such as growth promotion. These antibiotics are passed on to you in the meat and dairy you consume. Overuse of various antibiotics has been linked to antibiotic resistant infections like methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and the potentially life-threatening diarrhea caused by Clostridium difficile (C. diff). According to some research, being given fluoroquinolones is the most important risk factor in developing Clostridium difficile associated diarrhea (CDAD) The documentary Rise of the Superbugs details why antibiotic overuse is leading to the emergence of nightmare bacteria that have developed near-total resistance to today s antibiotics. Even gonorrhea and tuberculosis bacteria now have resistant strains. Again, a large part of the problem is that these drugs, which should be reserved for life-threatening infections that cannot otherwise be treated, are being vastly overprescribed. Physicians who prescribe in this manner are essentially trying to kill mosquitos with a stick of dynamite with collateral damage as described throughout this article.

Fluoroquinolones are thought to be particularly dangerous for children under age 18, adults over 60, and pregnant and nursing women, as well as for people with liver disease, diabetes, or those taking corticosteroids or nonsteroidal antiinflammatory drugs (DSAIDS). But they are often prescribed for these groups anyway, without even a passing thought. So in conclusion, if the patient s immune system is strong and is prescribed natural medicine alternatives, we can prevent needless pain and suffering from these harmful antibiotics. Our office is equipped with the best sources of natural medicines and products to have the same reaction(s) against the bacteria or pathogens which affect the American public. Dr. Badanek has been and currently is 37 years into active/private practice in the Ocala/Marion County, Florida region. Find him online at Dr.Badanek.com and wwww.alternativewholistic.com, and see what the facility has to offer the sick and health challenged. To schedule an appointment call 352-622-1151